Fidelity Investments’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-687,366
Closed -$3.99M 4369
2019
Q1
$3.99M Sell
687,366
-501,946
-42% -$5.18M ﹤0.01% 2141
2018
Q4
$16M Buy
1,189,312
+454,112
+62% +$7.66M ﹤0.01% 1641
2018
Q3
$14.3M Sell
735,200
-2,063,240
-74% -$43.9M ﹤0.01% 1824
2018
Q2
$71.5M Buy
2,798,440
+1,698,341
+154% +$39.6M 0.01% 1106
2018
Q1
$22.2M Buy
+1,100,099
New +$25.7M ﹤0.01% 1677
2017
Q2
Sell
-19,999
Closed -$319K 2710
2017
Q1
$319K Sell
19,999
-190,100
-90% -$2.74M ﹤0.01% 2576
2016
Q4
$2.65M Sell
210,099
-867,423
-81% -$16.2M ﹤0.01% 2326
2016
Q3
$30.2M Sell
1,077,522
-40,365
-4% -$1.35M ﹤0.01% 1499
2016
Q2
$39.1M Sell
1,117,887
-80,235
-7% -$2.52M 0.01% 1376
2016
Q1
$32.8M Sell
1,198,122
-25,013
-2% -$737K ﹤0.01% 1428
2015
Q4
$41.9M Sell
1,223,135
-1,890,723
-61% -$59M 0.01% 1329
2015
Q3
$89.5M Sell
3,113,858
-211,847
-6% -$9.06M 0.01% 998
2015
Q2
$149M Buy
3,325,705
+38,605
+1% +$1.45M 0.02% 842
2015
Q1
$114M Buy
3,287,100
+2,749,745
+512% +$74.8M 0.01% 969
2014
Q4
$14.7M Buy
+537,355
New +$13M ﹤0.01% 1865

Other funds holding DPLO

Fidelity Investments's DPLO Position: Q2 2019 in Review

Fidelity Investments sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 687,366 shares — an estimated $3.99M sold.

Fidelity Investments first reported a position in DPLO in Q4 2014 and held it in 15 quarters. The position peaked at $149M in Q2 2015. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • Fidelity Investments reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • Fidelity Investments sold 687,366 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $3.99M.
  • Fidelity Investments first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 15 quarters.
  • Fidelity Investments's DIPLOMAT PHARMACY, INC. position peaked at $149M in Q2 2015.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Fidelity Investments's 13F filing for Q2 2019, filed 13 Aug 2019.